View Author

Pillay, M.

( M. Pillay)


paclitaxel patient plasma concentration cremophor el embolism blood pharmacokinetic sparreboom cancer cremophor fraction disposition study sample dialysis infusion perfusion taxol diagnosis course level equilibrium value strategy perfusion lung scan equilibrium dialysis ratio binding table rotterdam treatment implementation result verweij clearance anticoagulant distribution function phase perfusion scan loos wj paclitaxel fu stoter g metabolite analysis ventilation lung scan g -3h walle experiment paclitaxel disposition curve elimination system nooter stoter excretion nooter k administration dose levels 3- h i.v volume 225 mg /m erythrocyte 6 mg /ml van beek ejr 175 mg /m urine buffer march plasma samples presence verweij j april concentration-time angiography consensus compound serum vehicle




4 Most Recent Publications

Active implementation of a consensus strategy improves diagnosis and management in suspected pulmonary embolism (Article)
Berghout, A. Oudkerk, M. Hicks, S.G. Teng, T.H. Pillay, M. Buller, H.R.
2000-01-01
Measurement of fraction unbound paclitaxel in human plasma (Article)
Brouwer, E. Verweij, J. Bruijn, P. de Loos, W.J. Pillay, M. Buijs, D. Sparreboom, A.
2000-01-01
Cremophor EL-mediated alteration of paclitaxel distribution in human blood: clinical pharmacokinetic implications (Article)
Sparreboom, A. Zuylen, L. van Brouwer, E. Loos, W.J. Bruijn, P. de Gelderblom, A.J. Pillay, M. Nooter, K. Stoter, G. Verweij, J.
1999-04-01
Disposition of [G-(3)H]paclitaxel and cremophor EL in a patient with severely impaired renal function (Article)
Gelderblom, A.J. Verweij, J. Brouwer, E. Pillay, M. Bruijn, P. de Nooter, K. Stoter, G. Sparreboom, A.
1999-01-01